Titlebook: Ciprofloxacin i.v.; Defining Its Role in Christopher Garrard (Intensive Care Director) Conference proceedings 1994 Springer-Verlag Berlin H

GERM

書(shū)目名稱(chēng)Ciprofloxacin i.v.影響因子(影響力)




書(shū)目名稱(chēng)Ciprofloxacin i.v.影響因子(影響力)學(xué)科排名




書(shū)目名稱(chēng)Ciprofloxacin i.v.網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱(chēng)Ciprofloxacin i.v.網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱(chēng)Ciprofloxacin i.v.被引頻次




書(shū)目名稱(chēng)Ciprofloxacin i.v.被引頻次學(xué)科排名




書(shū)目名稱(chēng)Ciprofloxacin i.v.年度引用




書(shū)目名稱(chēng)Ciprofloxacin i.v.年度引用學(xué)科排名




書(shū)目名稱(chēng)Ciprofloxacin i.v.讀者反饋




書(shū)目名稱(chēng)Ciprofloxacin i.v.讀者反饋學(xué)科排名

barium-study

使乳化

Fretful

cacy, safety and therapeutic use of the antibiotic substance Ciprofloxacin. Of special interest for clinicians will be the clinical outcome in patients with nosocomial pneumonia and other infections of the lower respiratory tract.978-3-642-79100-0978-3-642-79098-0

接觸

foliage

foliage

A Survey of Recent Developments,The safety profile of ciprofloxacin has been established in clinical trials since 1983 [1–4]. Postmarketing experience also contributes to this knowledge [5, 6]. Recently two pharmacoepidemiological studies have supported the known safety profile of ciprofloxacin in large outpatient populations [7, 8].

thwart

終端

Ciprofloxacin in Neutropenic Host Infection,The most frequent complication of granulocytopenia is infection which, if left untreated, often leads to death. As early as 1966 a retrospective analysis conducted in patients with acute leukemia confirmed that the depth and duration of neutropenia is inversely proportional to the risk of life-threatening infection [1].

舉止粗野的人